HOME ABOUT CONTACT AVAILABLE ISSUES SUBSCRIBE MEDIA & ADS
LATEST UPDATES » Vol 22, No 06, June 2018 – Cancer - Therapies and strategies for better patient outcomes       » Gardasil 9 supply running short in Hong Kong       » China helps Tajikistan tackle grassland degradation       » Immuno-oncology trials in China surge more than 50 per cent       » Yeast for industrial biotechnology       » Uncontrolled hypertension in rural communities      
BIOBOARD For e-subscribers (PDF)
Vol 21, No 09, September 2017
JAPAN
Potential drug for treating chronic pain with few side effects

Typical drugs for treating chronic pain - a condition estimated to affect 20 to 25 per cent of the world's population - often cause serious side effects such as stomach problems, kidney failure or addiction. Now, a team of researchers led by Yuri Kato and Takaaki Miyaji from Okayama University has identified a compound, clodronate, that inhibits the mechanism triggering chronic pain while having few side effects.

AUSTRALIA
Fellowship supports search for new disease treatments

La Trobe University and leading Australian biotech company AdAlta have received new funding to identify and develop potential treatments for a range of human diseases using the company's novel class of drugs, known as i-bodies.

TAIWAN
A novel platform for neurodegenerative disease studies: Applying photocontrollable probe to induce pathological proteins into amyloid fibers in live cells

Within many currently developed photochemical toolboxes, light would be one of the best triggers to initiate and directly observe the process of TDP-43 amyloidogenesis in vivo. This platform can be widely applied in the studies of aggregation-induced protein mislocalization, amyloid-induced pathogenesis, and protein misfolding in neurodegenerative diseases.

CLEC5A is critical in innate immunity against bacterial infections

CLEC5A is involved in several firstline immune responses, namely, neutrophil extracellular trap (NET) formation, and production of reactive oxygen species (ROS) and proinflammatory cytokines, in response to Listeria infection.

SINGAPORE
Singapore scientists uncover how neural stem cells are activated intrinsically by spindle matrix proteins

This discovery is an early important step towards opening up avenues for further research that could lead to potential stem cell-based therapies for neurodevelopmental and neurodegenerative disorders such as microcephaly and Alzheimer's disease.

NUS establishes additive manufacturing facilities for biomedical applications

The new centre will work with industry and local hospitals to support adoption of advanced manufacturing technology in Singapore's healthcare sector.

SINGAPORE & GERMANY
Breakthrough immunotherapy for Chronic Hepatitis B virus infection

The research utilizes molecular biology techniques to modify the T cells of a patient. When infused back into the patient's body, the TCR redirected T lymphocytes find, recognize and inhibit or clear the hepatitis B virus in hepatocyte.

SINGAPORE, HONG KONG & SOUTH KOREA
First in Asia - Launch of multi-centre lung cancer research platform

Some upcoming studies include lung cancer registries and clinical trials for defined molecular subsets of lung cancer, as well as evaluation of treatment paradigms involving novel clinical endpoints and immuno-oncology drugs

SINGAPORE & TAIWAN
ASLAN Pharmaceuticals collaborates with Academia Sinica's Genomic Research Centre

The new research collaboration will evaluate the effectiveness of combining varlitinib and ASLAN003 in animal models for gastric, colorectal and lung cancers.

GERMANY
ASIT biotech announces follow-up study of Phase I/IIβ clinical trial for house dust mite rhinitis

A subset of patients treated during the Phase I/IIβ clinical trial with its hdm-ASIT+TM product candidate for house dust mite rhinitis will undergo a complementary medical visit to assess potential long-term effect of hdm-ASIT+TM.

USA
Test uses nanotechnology to quickly diagnose Zika virus

Washington University in St. Louis researchers have developed a test that quickly detects the presence of Zika virus in blood.

NEWS CRUNCH  
news Shire, Microsoft and EURORDIS form Global Commission to accelerate time to diagnosis for children with rare diseases
news EmTech Asia explores future of life, humanity and economy
news Biology of Ageing II - Impactful Interventions
PR NEWSWIRE  
Asia Pacific Biotech News
EDITORS' CHOICE  
COLUMNS  
Click here to receive APBN e-newsletters once a month!

APBN Editorial Calendar 2018
January:
Obesity / Outlook for 2018
February:
Searching for the fountain of youth
March:
Women in Science - Making a difference
April:
Digestive health in the 21st century - Trust your guts
May:
Dental health - The root to good health
June:
Cancer - Therapies and strategies for better patient outcomes
July:
Water management / Vaccination
August:
Regenerative medicine / Biotech start ups
September:
Digital healthcare / 3D printing
October:
Bones / Breast cancer
November:
Liver health / Top science research nations & institutions
December:
AIDS / Breakthrough of the year/Emerging trends
Editorial calendar is subjected to changes.
MAGAZINE TAGS
About Us
Events
Available issues
Editorial Board
Letters to Editor
Instructions to Authors
Advertise with Us
CONTACT
World Scientific Publishing Co. Pte. Ltd.
5 Toh Tuck Link, Singapore 596224
Tel: 65-6466-5775
Fax: 65-6467-7667
» For Editorial Enquiries:
   biotech_edit@wspc.com or Ms Lim Guan Yu
» For Subscriptions, Advertisements &
   Media Partnerships Enquiries:
   biotech_ad@wspc.com
Copyright© 2018 World Scientific Publishing Co Pte Ltd  •  Privacy Policy